Denver, CO (PRWEB) January 28, 2008
LegalView.com, the number one resource for everything legal on the Web, recently added two new practice areas to its online library of information portals. The new practice areas include information on recent Vytorin news as well as a recently published Zetia study; both are oral drugs that are used to control the cholesterol levels of patients. However, a study released this month found that both are unlikely to lower a patient's risk of heart disease. LegalView unveils these information portals to remind readers of the different varieties of medications available and that it is always imperative that users understand the potential risks and issues associated with these drugs.
Vytorin was approved in 2004 and it is the combination of two drugs ezetimibe, also known as Zetia, and simvastatin, also Zocor. Zocor is the generic version of Vytorin and a study that was recently released found that Vytorin not only costs nearly three times more than the generic version but also doesn't have any greater benefits than the generic version. While the drug's manufacturers, Merck and Schering-Plough, allege that the drug is beneficial to users by decreasing the amount of cholesterol absorbed by patients when eating, the study found that Vytorin had no benefit on the buildup of arterial plaque. If you or someone you know is currently taking Vytorin or Zetia, it is advisable to contact an experienced Vytorin lawyer or a Zetia law firm specializing in the subject.
Zetia was approved in late 2002 and is the part of Vytorin that reduces the total and LDL cholesterol in the blood. However, in addition to having been found to have no benefit on arterial plaque buildup, there is a list of potential Zetia side effects including stomach pain, muscle and joint pain, weakness or tiredness within the body as well as the potential for allergic reaction. For individuals who are taking or have previously been prescribed either of the medications it is important to discuss the potential legal case that exists with an experienced Zetia attorney or Vytorin law firm.
In addition to these new information portals, LegalView has an extensive online library of practice areas to ease the troubles of individuals needed information regarding legal issues such as mesothelioma cancer or Nephrogenic Systemic Fibrosis (NSF), as well as traumatic brain injury. Mesothelioma cancer is an incurable illness that takes years to develop and is usually misdiagnosed among victims. It is caused by exposure to asbestos dust and asbestos fibers decades earlier. To learn about potential compensation for those who have this cancer, contact a mesothelioma lawyer.
For those who have been diagnosed with the rare but painful NSF illness, it is advisable to get into direct contact with an NSF attorney who may be able to offer a free consultation on the situation. NSF is a fairly recent discovery in the medical world and while the cause of NSF is yet to be determined, those who have the illness usually had undergone some type of magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) tests for kidney disease in which they have received gadolinium dye. And for the those who are part of the millions of Americans suffering from a traumatic brain injury (TBI) not only is it important to contact a medical professional to assess the injury, by receiving a Brain Injury attorney consultation you will better be able to find the support necessary to overcome the injury.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com.